- Home
- ARVN vs IIPR Comparison
ARVN vs IIPR Comparison
Compare ARVN & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- IIPR
- Stock Information
- Founded
- ARVN 2015
- IIPR 2016
- Country
- ARVN United States
- IIPR United States
- Employees
- ARVN N/A
- IIPR N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- IIPR Real Estate
- Sector
- ARVN Health Care
- IIPR Finance
- Exchange
- ARVN Nasdaq
- IIPR Nasdaq
- Market Cap
- ARVN 1.8B
- IIPR 2.1B
- IPO Year
- ARVN 2018
- IIPR 2016
- Fundamental
- Price
- ARVN $18.48
- IIPR $73.50
- Analyst Decision
- ARVN Strong Buy
- IIPR Buy
- Analyst Count
- ARVN 13
- IIPR 6
- Target Price
- ARVN $63.00
- IIPR $113.20
- AVG Volume (30 Days)
- ARVN 967.8K
- IIPR 356.0K
- Earning Date
- ARVN 10-30-2024
- IIPR 11-06-2024
- Dividend Yield
- ARVN N/A
- IIPR 10.32%
- EPS Growth
- ARVN N/A
- IIPR N/A
- EPS
- ARVN N/A
- IIPR 5.61
- Revenue
- ARVN $161,100,000.00
- IIPR $310,929,000.00
- Revenue This Year
- ARVN $237.44
- IIPR N/A
- Revenue Next Year
- ARVN N/A
- IIPR $2.90
- P/E Ratio
- ARVN N/A
- IIPR $13.14
- Revenue Growth
- ARVN 1.07
- IIPR 3.36
- 52 Week Low
- ARVN $17.37
- IIPR $70.88
- 52 Week High
- ARVN $53.08
- IIPR $138.35
- Technical
- Relative Strength Index (RSI)
- ARVN 32.78
- IIPR 12.26
- Support Level
- ARVN $17.37
- IIPR $105.26
- Resistance Level
- ARVN $19.21
- IIPR $102.91
- Average True Range (ATR)
- ARVN 1.64
- IIPR 3.17
- MACD
- ARVN -0.59
- IIPR -1.98
- Stochastic Oscillator
- ARVN 11.80
- IIPR 6.61
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.